Loading...
USANA Health Sciences, Inc.
USNA•NYSE
Consumer Defensive
Packaged Foods
$31.95
$-0.14(-0.44%)
USANA Health Sciences, Inc. (USNA) Financial Performance & Income Statement Overview
Review USANA Health Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-7.22%
↓ 7.22%
Operating Income Growth
-28.74%
↓ 28.74%
Net Income Growth
-34.11%
↓ 34.11%
Operating Cash Flow Growth
-13.66%
↓ 13.66%
Operating Margin
6.25%
↑ 6.25%
Gross Margin
79.93%
↑ 79.93%
Net Profit Margin
3.80%
↑ 3.80%
ROE
6.42%
↑ 6.42%
ROIC
9.17%
↑ 9.17%
USANA Health Sciences, Inc. (USNA) Income Statement & Financial Overview
Review USANA Health Sciences, Inc.'s (USNA) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $235.85M | $249.54M | $213.61M | $200.22M |
| Cost of Revenue | $50.18M | $52.45M | $38.55M | $39.26M |
| Gross Profit | $185.66M | $197.09M | $175.06M | $160.96M |
| Gross Profit Ratio | $0.79 | $0.79 | $0.82 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $168.95M | $91.44M | $73.35M | $61.30M |
| Operating Expenses | $168.95M | $181.42M | $166.85M | $145.36M |
| Total Costs & Expenses | $219.13M | $181.42M | $205.40M | $184.62M |
| Interest Income | $619000.00 | $723000.00 | $2.74M | $3.14M |
| Interest Expense | $259000.00 | $411000.00 | $129000.00 | $49000.00 |
| Depreciation & Amortization | $9.60M | $10.24M | $5.88M | $5.56M |
| EBITDA | $28.68M | $27.39M | $16.44M | $24.22M |
| EBITDA Ratio | $0.12 | $0.11 | $0.08 | $0.12 |
| Operating Income | $16.72M | $15.67M | $8.21M | $15.60M |
| Operating Income Ratio | $0.07 | $0.06 | $0.04 | $0.08 |
| Other Income/Expenses (Net) | $2.10M | $1.07M | $2.22M | $3.007M |
| Income Before Tax | $18.82M | $16.74M | $10.43M | $18.61M |
| Income Before Tax Ratio | $0.08 | $0.07 | $0.05 | $0.09 |
| Income Tax Expense | $8.37M | $7.45M | $5.95M | $8.001M |
| Net Income | $9.65M | $9.40M | $4.48M | $10.61M |
| Net Income Ratio | $0.04 | $0.04 | $0.02 | $0.05 |
| EPS | $0.52 | $0.49 | $0.24 | $0.56 |
| Diluted EPS | $0.52 | $0.49 | $0.23 | $0.56 |
| Weighted Avg Shares Outstanding | $18.51M | $19.05M | $19.06M | $19.08M |
| Weighted Avg Shares Outstanding (Diluted) | $18.54M | $19.09M | $19.10M | $19.08M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan